	Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death-Ligand 1 Expression and F-18-Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Cancer Med Sun M, Aikedan A, Rui Z, Ding E, Shen J. PMID: 42267455 [PubMed - in process]
	Systemic Inflammation and Nutritional Index as a prognostic marker in endometrial cancer. Biomol Biomed Kolk, Erdo, , , Ekinci F. PMID: 42267392 [PubMed - as supplied by publisher]
	Ki67 proliferation index augments two-tier tumour grade in prediction of survival and progression-free survival in epithelioid pleural mesothelioma. ERJ Open Res Lynch GA, Zhang YZ, Bhatt N, Charters P, Aujayeb A, Walker S, Symonds J, Clive AO, Bhatnagar R, Morley A, White P, Nicholson AG, Maskell NA, Bibby A. PMID: 42267369 [PubMed]
	Crosstalk of the Hippo/YAP pathway in the progression of oral potentially malignant disorders to oral squamous cell carcinoma: a systematic review. Front Oral Health Kazemi KS, de Castro Costa M, de Carli ML, Leask A, Franca CM, Sperandio FF. PMID: 42267337 [PubMed]
	The Emerging Role of Nanocarrier-Based Delivery Systems for cGAS-STING Activation in Cancer Immunotherapy. Int J Nanomedicine Zhu G, Li D, Zhang H, Wang J, Li X, Zeng L, Zhang L, Yu L. PMID: 42267310 [PubMed - in process]
	The association between activity patterns and malignant neoplasms of female genital organs: a prospective cohort study of UK biobank. Front Endocrinol (Lausanne) Li X, Yu H, Teng Y, Guo H, Liu Y, Zhang D, Han T. PMID: 42267296 [PubMed - in process]
	Unmet supportive care needs among head and neck cancer survivors in China: multicenter cross-sectional study. Front Public Health Xie J, Huang Y, Liang Q, Zhang M, Liu X, Ding L, Peng R, Chen B, Zuo Y, Ren A, Xu M, Yu R. PMID: 42267283 [PubMed - in process]
	Lung cancer in never-smoking females: epidemiology, risk factors and screening. Front Public Health Ding Y, Tao H, Zhu C, Li H, Zhang Y, Du Y, Du L, Gong W, Wang L. PMID: 42267273 [PubMed - in process]
	When Resectability Emerges After Systemic Therapy in Hepatocellular Carcinoma: A Proposed Response-Guided Consolidation Framework. J Hepatocell Carcinoma Cheng Y, Xie K. PMID: 42267214 [PubMed]
	Impact of Microwave Ablation on Growth Kinetics of Residual versus Synchronous Untreated Hepatocellular Carcinoma: A Retrospective Cohort Study. J Hepatocell Carcinoma Yi W, Pang C, Xue J, Zhang Y, Chen X, Luo T, Zhang D, Gao X, Yu J, Liang P. PMID: 42267213 [PubMed]
	Invasive stratified mucin-producing carcinoma of the uterine cervix masquerading as squamous cell carcinoma on biopsy: a diagnostic pitfall. Oxf Med Case Reports Okubo Y, Wada S, Yuguchi S, Yokozawa T, Saji H, Miyagi Y. PMID: 42267209 [PubMed]
	Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma. Cancer Drug Resist Zhang Y, Zhu Y, Liu Z, Li H, Zhong B, Cui X, Kong Y, Lu H. PMID: 42267194 [PubMed]
	Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer. Cancer Drug Resist Li L, Zhao Y, Shi X, Guo X, Zhang X, Li G, Meng Q, Zhang M, Yin M. PMID: 42267193 [PubMed]
	Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy. Cancer Drug Resist Da E, Zhu R, Xi B, Zhang L, Tang G. PMID: 42267192 [PubMed]
	Auricular acupuncture for insomnia in female patients with non-metastatic breast cancer: study protocol for a multicenter, randomized, controlled clinical trial. Front Psychiatry Liu L, Jiang S, Ye M, Zhang Y, Guo Z, Hu Y, Wang X, Chen Y, Jin Y, Zhu W, Yin P. PMID: 42267158 [PubMed]
	Radon Exposure as an Occupational Hazard and Environmental Risk Factor for Lung Cancer in Utah: Assessment, Mitigation, and Policy Implications. J Registry Manag Daramola O. PMID: 42267114 [PubMed - in process]
	Evaluation of Cancer Cases Reported through Inter-Registry Data Exchange in New York State. J Registry Manag Musco J, Qiao B, Homich A, Kuliszewski MG, Insaf TZ. PMID: 42267110 [PubMed - in process]
	The benefit and risk of adding PD-1/PD-L1 inhibitors plus anti-VEGF drugs to transarterial chemoembolisation for unresectable, non-metastatic hepatocellular carcinoma: a pooled analysis of four RCTs. Front Med (Lausanne) Zhou T, Yu C, Zhong B, Wang L, Zeng X, Wang Y. PMID: 42266951 [PubMed]
	Host-microbiome interactions in breast cancer progression and treatment response. Front Med (Lausanne) Bautista J, Lara-Hernández ME, Hidalgo-De La Cruz M, Andino-Araque V, León-Rivera M, López-Cortés A. PMID: 42266934 [PubMed]
	A novel integrated inflammation response score (IIRS) for predicting all-cause and cardiovascular mortality among cancer survivors. Am J Cancer Res Liu Z, Li X, Li Z. PMID: 42266760 [PubMed]

Articles 1 - 20 / 1941676

Page 1 of 97084



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy